The target action date for Rexulti in combination with sertraline to treat patients with post-traumatic stress disorder, ...

Out of 6,540 patients involved in a study, 7.1% of those with AD had mobility impairment compared to 3.9% of those without AD ...

U.S. approved the RSVpreF vaccine for adults 60 years and older in 2023, recommending it only based on individual’s decisions ...

Health plans will need to navigate a difficult financial environment caused by increased healthcare costs and potential ...

The target action date for Rexulti in combination with sertraline to treat patients with post-traumatic stress disorder, ...

Fianlimab plus Libtayo demonstrated persistent and significant clinical activity in patients with advanced melanoma.

Kerenida is currently approved to slow the progression chronic kidney disease associated with type 2 diabetes.

Regulators say, however, the benefits of vaccination with Abrysvo and Arexvy in preventing respiratory syncytial virus ...

A small study of 18 patients with skin cancer found that the combination of vitamin D and chemotherapy provided an immune ...

Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...

The updated guidelines from the American Diabetes Association emphasize the use of antibody-based screening for type 1 ...

Predictions for this year from Perry Cohen, Pharm.D., CEO of the TPG Family of Companies and Managed Healthcare Executive ...